Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Portable control systems to operate a hand motor neuroprosthesis for people with tetraplegia

Official title: Evaluation of Non-invasive Control Interfaces for Operating Assistive Devices for Tetraplegic Individuals

Run by Centre Bouffard Vercelli - USSAP · NCT07058506 · Data updated 2026-11-12

The study will test whether several fully portable, non‑invasive control methods (for example shoulder‑motion IMUs, surface EMG, touch/contact sensors, and voice) let adults with tetraplegia reliably control a hand motor neuroprosthesis.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorCentre Bouffard Vercelli - USSAP
Academic / other
Locations1 site (Perpignan)
StatusRecruiting
StartedNovember 18, 2024
Main results expectedNovember 18, 2024
Study endsDecember 31, 2025
Registry record updatedJuly 10, 2025
Trial IDNCT07058506 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with a cervical spinal cord injury (AIS A, B, or C), neurologically stable for at least 3 months, who can follow instructions and attend testing sessions are the intended participants.

Probably not a fit

People with unstable neurologic status, cognitive impairment or legal restrictions on consent, those deprived of liberty, or those without the required social security coverage may not be eligible or likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares multiple non‑invasive control interfaces that capture user intent to operate a motor neuroprosthesis delivering neural electrical stimulation for hand grasp. Participants will use each portable interface to control a software demonstration of a motor action while investigators measure reliability and precision of control. The work builds on prior demonstrations that neural stimulation can produce clinically useful grasping movements, but focuses on validating compact, wearable interfaces intended for integration with a future implanted stimulator. Eligible participants perform standardized tasks at the Perpignan rehabilitation center to generate comparable performance metrics across interfaces.

Why it matters

Potential benefit: If successful, these portable control interfaces could provide people with tetraplegia a practical way to trigger reliable grasping with a hand neuroprosthesis and improve daily independence.

How similar studies have gone: Previous clinical work has shown feasibility of neurostimulation‑induced grasping using external shoulder sensors, myoelectric signals, and implanted stimulators, but direct comparisons of multiple portable non‑invasive interfaces are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spinal cord injury defined by an AIS A, B or C score (AIS A, B or C): complete or incomplete motor deficit below the lesion. This is a standard for describing spinal cord injuries that has been internationally agreed upon.
* Spinal cord injury at the neurological level \> C7
* Age greater than or equal to 18 and less than or equal to 80 years
* A history of more than 3 months of neurological stability, with no changes in muscle testing.
* Participants capable of following instructions for testing and providing feedback on the use of the device.
* Participants who have signed the informed consent form to participate in the study after being fully informed.
* Participants affiliated with a social security system (either as a beneficiary or a dependent), excluding those covered by State Medical Aid (AME).

Exclusion Criteria:

* Participant deprived of liberty (by judicial or administrative decision).
* Adult participants are under legal protection or unable to provide informed consent.
* Participation in another ongoing clinical trial.
* Unstable psychiatric condition.
* Severe cognitive impairment.
* Unstable acute medical condition
* Insufficient proficiency in spoken and written French.

Where it's running

  • Rehabilitation Center Bouffard-Vercelli USSAP
    Perpignan, France
    Recruiting

Study contacts

  • Principal investigator: Charles FATTAL, MD, PhD — Centre Bouffard Vercelli - USSAP
  • Study coordinator: Charles FATTAL Charles FATTAL, MD, PhD
  • Email: cfattal@ussap.fr
  • Phone: +33 430441100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.